SCHEMBL18753487

SCHEMBL18753487

Cc1cc(C(=O)N2CCN(C(=O)c3ccccc3F)CC2)ccc1N[SH](=O)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ HTT P42858 5/20 0.51
▸ TSHR P16473 4/20 0.51
▸ MAPT P10636 2/20 0.51
▸ LMNA P02545 2/20 0.51
▸ CA12 O43570 1/20 0.50
▸ CA1 P00915 1/20 0.50
▸ CA2 P00918 1/20 0.50
▸ CA7 P43166 1/20 0.50
▸ CA9 Q16790 1/20 0.50
▸ CA14 Q9ULX7 1/20 0.50
▸ NAMPT P43490 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ ABL1 P00519 1/20 0.47
▸ BCR P11274 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ KDM4E B2RXH2 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18753353 0.91 HPGD (0.51) ALDH1A1L3MBTL1HTTTSHRMAPT
SCHEMBL18753373 0.90 ALDH1A1 (0.57) ALDH1A1L3MBTL1HTTTSHRMAPT
SCHEMBL18753740 0.87 LMNA (0.48) ALDH1A1HTTTSHRLMNACA12
SCHEMBL18753318 0.86 KMT2A (0.59) ALDH1A1HTTTSHRMAPTLMNA
SCHEMBL18753852 0.85 POLB (0.45) ALDH1A1L3MBTL1TSHRPOLBTP53
SCHEMBL18753349 0.83 PKLR (0.41) ALDH1A1L3MBTL1HTTTSHRLMNA
SCHEMBL18753372 0.80 HCRTR1 (0.46) ALDH1A1HTTTSHRLMNAABL1
SCHEMBL18753307 0.80 TSHR (0.47) ALDH1A1L3MBTL1HTTTSHRLMNA
SCHEMBL18753484 0.79 MYC (0.54) ALDH1A1TSHRLMNATP53ABL1
SCHEMBL18753767 0.79 ALDH1A1 (0.53) ALDH1A1L3MBTL1HTTTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3241554-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2020-01-29 — — EP disclosed
EP-3241554-A1 QUINOLINE-8-SULFONAMIDE DERIVATES HAVING AN ANTICANCER ACTIVITY Agios Pharmaceuticals, Inc. (US) 2017-11-08 — — EP disclosed
EP-2448582-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2017-04-19 — — EP disclosed
Send feedback